Adaptive-to-maladaptive IRE1α signaling as a driver of amyloidogenic APP processing in Alzheimer’s disease
How dynamic changes in IRE1α signaling bias contribute to amyloidogenic progression in AD is examined and whether selective modulation of adaptive versus maladaptive IRE1α outputs may offer stage-dependent therapeutic benefit is considered.